<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>During the past decade, studies on the manipulation of various inhaled <z:chebi fb="2" ids="33309">inert gases</z:chebi> during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and/or reperfusion have led to the conclusion that <z:chebi fb="2" ids="33309">inert gases</z:chebi> may be promising agents for treating <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> and perinatal <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> insults </plain></SENT>
<SENT sid="1" pm="."><plain>Although there is a general consensus that among these gases <z:chebi fb="3" ids="49957">xenon</z:chebi> is a golden standard, the possible widespread clinical use of <z:chebi fb="3" ids="49957">xenon</z:chebi> experiences major obstacles, namely its availability and cost of production </plain></SENT>
<SENT sid="2" pm="."><plain>Interestingly, recent findings have shown that <z:chebi fb="64" ids="30217">helium</z:chebi>, which is a cost-efficient inert gas with no <z:chebi fb="164" ids="38867">anesthetic</z:chebi> properties, can provide neuroprotection against <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> in vivo when administered during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and early reperfusion </plain></SENT>
<SENT sid="3" pm="."><plain>We have investigated whether <z:chebi fb="64" ids="30217">helium</z:chebi> provides neuroprotection in rats subjected to middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) when administered after reperfusion, a condition prerequisite for the therapeutic viability and possible clinical use of <z:chebi fb="64" ids="30217">helium</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>In this study, we show that <z:chebi fb="64" ids="30217">helium</z:chebi> at 75 vol% produces neuroprotection and improvement of neurologic outcome in rats subjected to transient MCAO by producing <z:hpo ids='HP_0002045'>hypothermia</z:hpo> on account of its high specific heat as compared with air </plain></SENT>
</text></document>